Exane Derivatives’s D.R. Horton DHI Stock Holding History

Exane Derivatives’s Portfolio DHI Stock Details DHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$552K	Sell	8,336 -3,309	-28%	-$233K	0.32%	73
2022 Q1	$868K	Buy	11,645 +1,762	+18%	+$153K	0.24%	110
2021 Q4	$1.07M	Buy	9,883 +9,522	+2,638%	+$917K	0.26%	81
2021 Q3	$30.3K	Sell	361 -4,400	-92%	-$405K	0.01%	665
2021 Q2	$412K	Buy	4,761 +3,714	+355%	+$349K	0.09%	228
2021 Q1	$93.3K	Sell	1,047 -6,366	-86%	-$498K	0.03%	429
2020 Q4	$511K	Buy	7,413 +7,387	+28,412%	+$539K	0.15%	151
2020 Q3	$1.97K	Sell	26 -36,408	-100%	-$2.49M	﹤0.01%	565
2020 Q2	$2.02M	Buy	36,434 +25,985	+249%	+$1.26M	0.54%	50
2020 Q1	$355K	Buy	10,449 +10,394	+18,898%	+$540K	0.1%	146
2019 Q4	$3.02K	Sell	55 -191	-78%	-$10.2K	﹤0.01%	468
2019 Q3	$13K	Buy	246 +237	+2,633%	+$11.3K	﹤0.01%	415
2019 Q2	$388	Sell	9 -1	-10%	-$44	﹤0.01%	611
2019 Q1	$414	Sell	10 -864	-99%	-$33.8K	﹤0.01%	547
2018 Q4	$30.3K	Sell	874 -25,806	-97%	-$941K	0.01%	413
2018 Q3	$1.13M	Buy	26,680 +26,065	+4,238%	+$1.13M	0.21%	103
2018 Q2	$25.4K	Sell	615 -51	-8%	-$2.2K	﹤0.01%	418
2018 Q1	$28.8K	Sell	666 -30,361	-98%	-$1.42M	0.01%	380
2017 Q4	$1.58M	Buy	31,027 +30,723	+10,106%	+$1.43M	0.27%	65
2017 Q3	$12.1K	Sell	304 -23	-7%	-$838	﹤0.01%	384
2017 Q2	$11.3K	Sell	327 -556	-63%	-$18.6K	﹤0.01%	386
2017 Q1	$29.4K	Buy	883 +881	+44,050%	+$27.3K	0.01%	303
2016 Q4	$55	Sell	2 -350	-99%	-$10K	﹤0.01%	570
2016 Q3	$10.6K	Buy	352 +1	+0.3%	+$32	﹤0.01%	397
2016 Q2	$11K	Sell	351 -77	-18%	-$2.35K	﹤0.01%	363
2016 Q1	$12.9K	Sell	428 -257	-38%	-$7.06K	﹤0.01%	399
2015 Q4	$21.9K	Sell	685 -231	-25%	-$7.21K	﹤0.01%	291
2015 Q3	$26.9K	Sell	916 -601	-40%	-$17.7K	﹤0.01%	306
2015 Q2	$41.5K	Sell	1,517 -1,609	-51%	-$43.3K	﹤0.01%	298
2015 Q1	$89K	Sell	3,126 -453	-13%	-$11.8K	0.01%	275
2014 Q4	$90.5K	Buy	+3,579	New	+$83.7K	0.01%	293

Other funds holding DHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ECU

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Exane Derivatives's DHI Position: Q2 2022 in Review

Exane Derivatives reduced its D.R. Horton (DHI) stake by 28% in Q2 2022, selling an estimated $233K and leaving 8,336 shares worth $552K. The position accounts for 0.32% of the portfolio, ranked #73.

Exane Derivatives first reported a position in DHI in Q4 2014 and has held it in 31 quarters since. The position peaked at $2.02M in Q2 2020. 843 funds tracked by Wall St. Rank hold DHI as of Q2 2022.

Exane Derivatives held 8,336 shares of D.R. Horton worth $552K as of Q2 2022.
Exane Derivatives sold 3,309 D.R. Horton shares in Q2 2022, an estimated $233K.
D.R. Horton made up 0.32% of Exane Derivatives's portfolio in Q2 2022, its #73 holding.
Exane Derivatives first reported a position in D.R. Horton in Q4 2014 and has held it in 31 quarters since.
Exane Derivatives's D.R. Horton position peaked at $2.02M in Q2 2020.
843 funds tracked by Wall St. Rank held D.R. Horton as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.